SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2003
Bio-Technology General Corp.
(Exact name of issuer as specified in its charter)
Delaware |
| 0-15313 |
| 13-3033811 | ||
(State or Other Jurisdiction |
| (Commission File Number) |
| (IRS Employer | ||
|
|
|
|
| ||
One Tower Center, 14th Floor |
| 08816 | ||||
(Address of Principal Executive Offices) |
| (Zip Code) | ||||
Registrant’s telephone number, including area code: (732) 418-9300
None.
(Former Name or Former Address, if Changed Since Last Report.)
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
99.1 Transcript of the conference call discussing Bio-Technology General Corp.'s earnings results for the quarter ended March 31, 2003 held on May 1, 2003.
ITEM 9. REGULATION FD DISCLOSURE.
Filed herewith as Exhibit 99.1 is a transcript of the conference call discussing Bio-Technology General Corp.'s earnings results for the quarter ended March 31, 2003 held on May 1, 2003.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
| BIO-TECHNOLOGY GENERAL CORP. | ||
|
|
|
| (Registrant) | ||
|
|
|
|
| ||
|
|
|
|
|
| |
|
|
|
| By: | /s/ Whitney K. Stearns, Jr. |
|
|
|
|
|
| Whitney K. Stearns, Jr. | |
|
|
|
|
| Senior Vice President—Chief Financial Officer and Treasurer | |
Dated: May 2, 2003
3
